Read Trending Stories
- » Healthcare Biz Recap: Rosetta Genomics Spikes, Dynasil Pops, J&J Ticks Up
- » Traders Fret Over Direction: Europe's Woes and a Faceplant Bloom
- » Rearview Snapshot: Apple Rejects U.S. Govt, HP Shines, Oil Rebounds
- » Tech Biz Recap: H-P's Earnings Reaction, Facebook's New App
- » Is Facebook Competing With Itself With Photo-Sharing App?
Today's Trending Stocks
Click a Company to Research Now:
- Bank of America (BAC)
- Apple . (AAPL)
- Facebook (FB)
- AT&T (T)
- Nokia (NOK)
- Tiffany & Co. (TIF)
- Signet Jewelers Ltd. (SIG)
- NetApp . (NTAP)
General Motors Corporation (NYSE:GM): Sterne Agee said European results and expected restructuring charges present near-term risk to shares. The firm rates General Motors a Buy and would wait for a better entry point following the February 16 earnings.
Parkway Properties Inc. (NYSE:PKY): JMP Securities is upbeat about Parkway’s disposition program and its strategic plan. The firm lowered its target to $15 from $17 but reiterates an Outperform rating.
Regal Beloit Corporation (NYSE:RBC): JMP Securities increased its target on Regal-Beloit after the company reported Q4 results that the firm views as strong. The firm maintains an Outperform rating on the stock.
MAKO Surgical Corp. (NASDAQ:MAKO): RBC Capital said most of the high volume surgeons they spoke to showed little interest in MAKOplasty due to high cost of the RIO system and implants.
Fifth Third Bancorp (NASDAQ:FITB): Fifth Third speaking positively about auto loan growth, says Credit Suisse.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.
To contact the reporter on this story: Derek Hoffman at staff.writers@wallstcheatsheet.com
To contact the editor responsible for this story: Damien Hoffman at editors@wallstcheatsheet.com
Get Your FREE Special Report: 4 Things You Must Know About the US Economy Now!
Do You Want More Profits? Wall St. Cheat Sheet Premium newsletter subscribers have been crushing the markets with winning stock picks.
Click here now for your FREE trial to our acclaimed flagship newsletter:
